scholarly journals Duplex Ultrasound Screening for Deep and Superficial Vein Thrombosis in COVID‐19 Patients

2021 ◽  
Author(s):  
Yale Tung‐Chen ◽  
Ruth Calderón ◽  
Cristina Marcelo ◽  
Francesco Deodati ◽  
María Mateos ◽  
...  
Keyword(s):  
Duplex Ultrasound ◽  
Ultrasound Screening ◽  
Superficial Vein ◽  
Vein Thrombosis ◽  
Superficial Vein Thrombosis

Patterns in the management of superficial vein thrombosis

2016 ◽  
Vol 32 (3) ◽  
pp. 207-213 ◽  
Author(s):  
Christos Karathanos ◽  
Konstantinos Spanos ◽  
Vasileios Lachanas ◽  
Athanasios Athanasoulas ◽  
Athanasios D Giannoukas
Keyword(s):  
Duplex Ultrasound ◽  
Superficial Vein ◽  
Electronic Survey ◽  
Vein Thrombosis ◽  
Mailing Lists ◽  
Superficial Vein Thrombosis ◽  
Venous Diseases ◽  
Elastic Stockings ◽  
Inflammatory Drugs ◽  
Current Guidelines

Objective To highlight current practice patterns in management of superficial vein thrombosis. Methods An electronic survey was conducted using the mailing lists of the Mediterranean League of Angiology and Vascular Surgery and European Venous Forum regarding superficial vein thrombosis diagnosis, investigation, and treatment. Results The response rate was 41% (175/430) and the majority of the participants were vascular surgeons practicing in a hospital. More experienced physicians considered superficial vein thrombosis as a medical issue of moderate seriousness and performed duplex ultrasound for confirmation of diagnosis. Elastic stockings were recommended by 87% of the physicians, while 57% prescribed nonsteroidal anti-inflammatory drugs. Eighty six percent advised anticoagulation, although a large disparity was shown regarding regime, dose, and duration. Thrombophilia test was regularly suggested by 19% of the physicians. Ligation of the saphenofemoral junction was the treatment of choice by those who suggested intervention in the acute phase of superficial vein thrombosis. Conclusions A great disparity exists in the management of superficial vein thrombosis. Current guidelines have not been adopted by physicians; more focused training is needed for those involved in the management of venous diseases.

scholarly journals Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis

2003 ◽  
Vol 38 (5) ◽  
pp. 944-949 ◽  
Author(s):  
Sara Quenet ◽  
Silvy Laporte ◽  
Hervé Décousus ◽  
Alain Leizorovicz ◽  
Magali Epinat ◽  
...  
Keyword(s):  
Superficial Vein ◽  
Vein Thrombosis ◽  
Superficial Vein Thrombosis ◽  
Thrombotic Complications

Evaluation of direct oral anticoagulants in superficial-vein thrombosis – Authors' reply

2017 ◽  
Vol 4 (6) ◽  
pp. e254-e255
Author(s):  
Jan Beyer-Westendorf ◽  
Sebastian M Schellong ◽  
Horst Gerlach ◽  
Eberhard Rabe ◽  
Jeffrey I Weitz ◽  
...  
Keyword(s):  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Superficial Vein ◽  
Vein Thrombosis ◽  
Superficial Vein Thrombosis

scholarly journals Different Risks of Thrombosis in Four Coagulation Defects Associated With Inherited Thrombophilia: A Study of 150 Families

Blood ◽  
1998 ◽  
Vol 92 (7) ◽  
pp. 2353-2358 ◽  
Author(s):  
Ida Martinelli ◽  
Pier Mannuccio Mannucci ◽  
Valerio De Stefano ◽  
Emanuela Taioli ◽  
Valentina Rossi ◽  
...  
Keyword(s):  
Protein C ◽  
Factor V Leiden ◽  
Protein S ◽  
Factor V ◽  
Superficial Vein ◽  
Protein S Deficiency ◽  
Vein Thrombosis ◽  
S Deficiency ◽  
Superficial Vein Thrombosis ◽  
Coagulation Defects

AbstractDeficiency of the naturally occurring anticoagulant proteins, such as antithrombin, protein C and protein S, and activated protein C resistance due to the factor V Leiden gene mutation is associated with inherited thrombophilia. So far, no direct comparison of the thrombotic risk associated with these genetic defects is available. In this study, we wish to compare the lifetime probability of developing thrombosis, the type of thrombotic symptoms, and the role of circumstantial triggering factors in 723 first- and second-degree relatives of 150 index patients with different thrombophilic defects. We found higher risks for thrombosis for subjects with antithrombin (risk ratio 8.1, 95% confidence interval [CI], 3.4 to 19.6), protein C (7.3, 95% CI, 2.9 to 18.4) or protein S deficiency (8.5, 95% CI, 3.5 to 20.8), and factor V Leiden (2.2, 95% CI, 1.1 to 4.7) than for individuals with normal coagulation. The risk of thrombosis for subjects with factor V Leiden was lower than that for those with all three other coagulation defects (0.3, 95% CI, 0.1 to 1.6), even when arterial and superficial vein thromboses were excluded and the analysis was restricted to deep vein thrombosis (0.3, 95% CI, 0.2 to 0.5). No association between coagulation defects and arterial thrombosis was found. The most frequent venous thrombotic manifestation was deep vein thrombosis with or without pulmonary embolism (90% in antithrombin, 88% in protein C, 100% in protein S deficiency, and 57% in factor V Leiden), but a relatively mild manifestation such as superficial vein thrombosis was common in factor V Leiden (43%). There was a predisposing factor at the time of venous thromboembolism in approximately 50% of cases for each of the four defects. In conclusion, factor V Leiden is associated with a relatively small risk of thrombosis, lower than that for antithrombin, protein C, or protein S deficiency. In addition, individuals with factor V Leiden develop less severe thrombotic manifestations, such as superficial vein thrombosis.

The risk of lower-limb superficial vein thrombosis relative to lower-limb venous thrombotic events is not increased in winter months

2020 ◽  
Vol 35 (7) ◽  
pp. 533-537
Author(s):  
Samir Henni ◽  
Pierre Ramondou ◽  
Guillaume Duval ◽  
Jean Picquet ◽  
Georges Leftheriotis ◽  
...  
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Lower Limb ◽  
Homogeneous Distribution ◽  
Superficial Vein ◽  
Chi Square ◽  
Venous Flow ◽  
Vein Thrombosis ◽  
Superficial Vein Thrombosis ◽  
Chi Square Test

Objectives Ambient temperature (that impacts differently venous flow in superficial and deep veins) could have a different effect on the risk of superficial and deep venous thrombosis. We searched for a trimestral variation of the risk of superficial venous thrombosis among all lower-limb thrombotic events (lower-limb thrombotic events = superficial venous thrombosis + deep venous thrombosis). Methods We retrospectively analyzed the results of venous ultrasound investigations performed among 11,739 patients (aged 67 ± 19 years old, 56.1% males) referred for suspected lower-limb thrombotic events over a 12-year period. Chi-square test was used to compare the superficial venous thrombosis/lower-limb thrombotic events ratio observed by trimesters to a homogeneous distribution. Results The proportion of lower-limb thrombotic events were 30.7%, 28.8%, 31.1%, and 31.4% (Chi2: 0.133; p = 0.987) of total investigations, while that of superficial venous thrombosis among all lower-limb venous thrombotic events were 27.2%, 30.0%, 31.4%, and 31.0%, for the first, second, third, and fourth trimesters respectively (Chi2: 0.357; p: 0.949). Conclusion No trimestral variation of the superficial venous thrombosis/lower-limb venous thrombotic events ratio was observed.

Sonographic evolution of the superficial vein thrombosis of the lower extremity

2020 ◽  
Author(s):  
Y. Tung-Chen ◽  
I. Pizarro ◽  
M. A. Rivera-Núñez ◽  
A. M. Martínez-Virto ◽  
A. Lorenzo-Hernández ◽  
...  
Keyword(s):  
Lower Extremity ◽  
Superficial Vein ◽  
Vein Thrombosis ◽  
Superficial Vein Thrombosis
Sign in / Sign up

Export Citation Format

Share Document